# A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma

> **NCT06792422** · PHASE4 · RECRUITING · sponsor: **Glostrup University Hospital, Copenhagen** · enrollment: 126 (estimated)

## Conditions studied

- Primary Open Angle Glaucoma (POAG)
- Open-Angle Glaucoma
- Glaucoma

## Interventions

- **DRUG:** Oral semaglutide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06792422
- **Lead sponsor:** Glostrup University Hospital, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01
- **Primary completion:** 2028-08
- **Final completion:** 2028-12
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2025-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06792422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06792422, "A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06792422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*